Xenocor
PrivateLast Round
Series A
Apr 18, 2023
Total Funding Raised
$10M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Xenocor operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Series A round in April 2023.
Xenocor is a medical device company that develops and markets single-use, high-definition, fog-free laparoscopic imaging systems for minimally invasive surgical procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xenocor Comparables
Compare Xenocor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Outlook Surgical | 86% | |
| Contra Healthcare Solutions | 80% | |
| Pristine Surgical | 77% |
For institutional investors. Book with your work email.
Xenocor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 18, 2023 | ||||
| Strategic | Jun 22, 2021 | ||||
| Accelerator | Jun 15, 2021 | ||||
| Series A Extension | Apr 27, 2021 | ||||
| VC Round | Oct 5, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xenocor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GenHenn Capital | Series A |
| MedTech Innovator | Accelerator |
| Mountain Pacific Venture Fund | VC Round |
| Patel Family Investments | Series A |
| Growing Impact Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 48% MoM.
- May 17, 2026
Grew 33% QoQ from 9 to 12 employees.
For institutional investors. Book with your work email.
Xenocor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xenocor's valuation, stock price, and market status.
Is Xenocor a public or private company?
Xenocor is a private company.
What is the current stock price of Xenocor?
Xenocor is a private company, so its shares have no public market price. Caplight tracks Xenocor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xenocor worth (valuation)?
Valuation information for Xenocor is not publicly available.
Can I buy Xenocor stock?
Xenocor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xenocor's last funding round?
Xenocor's most recent funding round was Series A on April 18, 2023.
Who are the main investors in Xenocor?
Key investors in Xenocor include GenHenn Capital.
Will Xenocor IPO soon?
No public IPO plans have been announced for Xenocor.
How can I track Xenocor secondary market activity?
Caplight tracks bids, offers, and trades in Xenocor's shares on secondary markets.